Published in Antivir Ther on March 01, 2000
Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J Clin Microbiol (2005) 7.91
Diversity and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype. Proc Natl Acad Sci U S A (2002) 3.46
Genotypic testing for human immunodeficiency virus type 1 drug resistance. Clin Microbiol Rev (2002) 3.27
High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients. J Clin Microbiol (2001) 2.45
Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1. Antimicrob Agents Chemother (2004) 2.44
Geno2pheno: Estimating phenotypic drug resistance from HIV-1 genotypes. Nucleic Acids Res (2003) 2.37
Accuracy of the TRUGENE HIV-1 genotyping kit. J Clin Microbiol (2003) 2.32
Pharmacokinetic-pharmacodynamic analysis of lopinavir-ritonavir in combination with efavirenz and two nucleoside reverse transcriptase inhibitors in extensively pretreated human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (2003) 1.92
Performance characteristics of the TRUGENE HIV-1 Genotyping Kit and the Opengene DNA Sequencing System. J Clin Microbiol (2003) 1.73
Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool. J Clin Microbiol (2012) 1.48
Evaluation of the editing process in human immunodeficiency virus type 1 genotyping. J Clin Microbiol (2003) 1.46
Safety, pharmacokinetics, and antiretroviral activity of multiple doses of ibalizumab (formerly TNX-355), an anti-CD4 monoclonal antibody, in human immunodeficiency virus type 1-infected adults. Antimicrob Agents Chemother (2008) 1.39
Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patients. Antimicrob Agents Chemother (2005) 1.30
Variants other than aspartic acid at codon 69 of the human immunodeficiency virus type 1 reverse transcriptase gene affect susceptibility to nuleoside analogs. Antimicrob Agents Chemother (2001) 1.27
Broad phenotypic cross-resistance to elvitegravir in HIV-infected patients failing on raltegravir-containing regimens. Antimicrob Agents Chemother (2012) 1.24
HIV drug resistance and its impact on antiretroviral therapy in Chinese HIV-infected patients. PLoS One (2013) 1.16
The Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors. AIDS Rev (2000) 1.15
ACTG (AIDS Clinical Trials Group) 384: a strategy trial comparing consecutive treatments for HIV-1. Control Clin Trials (2001) 1.07
Determinants of human immunodeficiency virus type 1 resistance to membrane-anchored gp41-derived peptides. J Virol (2005) 1.06
Virtual inhibitory quotient predicts response to ritonavir boosting of indinavir-based therapy in human immunodeficiency virus-infected patients with ongoing viremia. Antimicrob Agents Chemother (2002) 1.02
The use of computational models to predict response to HIV therapy for clinical cases in Romania. Germs (2012) 1.01
Predictive value of HIV-1 genotypic resistance test interpretation algorithms. J Infect Dis (2009) 1.00
A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies. HIV Seq Compend (2001) 0.98
Clinical evaluation of the potential utility of computational modeling as an HIV treatment selection tool by physicians with considerable HIV experience. AIDS Patient Care STDS (2011) 0.95
Gln145Met/Leu changes in human immunodeficiency virus type 1 reverse transcriptase confer resistance to nucleoside and nonnucleoside analogs and impair virus replication. Antimicrob Agents Chemother (2004) 0.94
HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure. AIDS (2014) 0.93
Emerging trends of HIV drug resistance in Chinese HIV-infected patients receiving first-line highly active antiretroviral therapy: a systematic review and meta-analysis. Clin Infect Dis (2014) 0.92
HIV Drug Resistance Testing by High-Multiplex "Wide" Sequencing on the MiSeq Instrument. Antimicrob Agents Chemother (2015) 0.90
Genome-wide association study identifies single nucleotide polymorphism in DYRK1A associated with replication of HIV-1 in monocyte-derived macrophages. PLoS One (2011) 0.87
A randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patients. AIDS (2009) 0.86
HIV-1 drug resistance in treatment-naive chronically infected patients in Jamaica. Antivir Ther (2013) 0.82
The case for addressing primary resistance mutations to non-nucleoside reverse transcriptase inhibitors to treat children born from mothers living with HIV in sub-Saharan Africa. J Int AIDS Soc (2014) 0.81
Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience. HIV Clin Trials (2008) 0.81
Cost-effectiveness of newer antiretroviral drugs in treatment-experienced patients with multidrug-resistant HIV disease. J Acquir Immune Defic Syndr (2013) 0.80
The development of drug resistance mutations K103N Y181C and G190A in long term Nevirapine-containing antiviral therapy. AIDS Res Ther (2014) 0.79
Prevalence and pattern of drug resistance mutations among antiretroviral-treated HIV-1 patients with suboptimal virological response in Malaysia. Med Microbiol Immunol (2006) 0.78
Algorithm specification interface for human immunodeficiency virus type 1 genotypic interpretation. J Clin Microbiol (2003) 0.78
Surveillance of transmitted drug-resistant HIV among young pregnant women in Ouagadougou, Burkina Faso. Clin Infect Dis (2012) 0.78
Local phylogenetic analysis identifies distinct trends in transmitted HIV drug resistance: implications for public health interventions. BMC Infect Dis (2013) 0.77
The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients. PLoS Comput Biol (2013) 0.77
Ritonavir-saquinavir dual protease inhibitor compared to ritonavir alone in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (2001) 0.77
Low Virologic Failure and Drug Resistance among HIV-Infected Patients Receiving Hospital-Based ART While Care and Outreach through Community in Guangxi, China. Front Public Health (2015) 0.77
Transmitted HIV drug resistance in treatment-naive Romanian patients. J Med Virol (2013) 0.77
Prevalence of transmitted HIV drug resistance among newly diagnosed antiretroviral therapy-naive pregnant women in Lilongwe and Blantyre, Malawi. Clin Infect Dis (2012) 0.75
Pretreatment HIV-1 drug resistance is strongly associated with virologic failure in HIV-infected patients receiving partly active antiretroviral regimens. Future Microbiol (2012) 0.75
What do molecules do when we are not looking? State sequence analysis for stochastic chemical systems. J R Soc Interface (2012) 0.75
An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype. J Antimicrob Chemother (2016) 0.75
Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008-2012: a prospective cohort study. BMJ Open (2017) 0.75
CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med (2006) 22.76
Segmental aneuploidy and the genetic gross structure of the Drosophila genome. Genetics (1972) 22.68
Health and behavioral consequences of binge drinking in college. A national survey of students at 140 campuses. JAMA (1994) 12.32
Why do people sue doctors? A study of patients and relatives taking legal action. Lancet (1994) 10.79
European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr (2012) 10.61
Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet (1998) 7.53
Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. Science (1989) 7.15
Genetic engineering of Schizosaccharomyces pombe: a system for gene disruption and replacement using the ura4 gene as a selectable marker. Mol Gen Genet (1988) 6.35
A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs. Antimicrob Agents Chemother (1998) 5.64
Correlates of college student binge drinking. Am J Public Health (1995) 5.60
Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol (1978) 5.22
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories. J Clin Microbiol (1996) 4.81
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA (1999) 4.71
Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial. Lancet (1999) 4.68
EXPERIMENTAL HYPOSTHENURIA. J Clin Invest (1939) 4.64
Genome sequence, comparative analysis, and population genetics of the domestic horse. Science (2009) 4.41
Interleukin-2 therapy in patients with HIV infection. N Engl J Med (2009) 4.38
The adverse impact of heavy episodic drinkers on other college students. J Stud Alcohol (1995) 4.34
HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet (2001) 4.33
Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science (1984) 4.27
Inventory of Complicated Grief: a scale to measure maladaptive symptoms of loss. Psychiatry Res (1995) 4.17
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. Ann Intern Med (2008) 3.68
Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet (1999) 3.61
Dynamic repositioning of genes in the nucleus of lymphocytes preparing for cell division. Mol Cell (1999) 3.47
The superficial femoral vein. A potentially lethal misnomer. JAMA (1995) 3.40
A formalin-inactivated whole SIV vaccine confers protection in macaques. Science (1989) 3.37
ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results. AIDS (2001) 3.35
Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. Immunity (1997) 3.33
Inhibition of human immunodeficiency virus gene amplification by heparin. J Clin Microbiol (1991) 3.32
Detection of vancomycin resistance in Enterococcus species. J Clin Microbiol (1992) 3.30
Diabetes mellitus in American (Pima) Indians. Lancet (1971) 3.30
Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission. Proc Natl Acad Sci U S A (2006) 3.26
Health care crisis from a trauma center perspective: The LA story. JAMA (1996) 3.24
Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J Exp Med (1998) 3.24
A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Arch Gen Psychiatry (1997) 3.11
Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy. J Virol (2001) 3.05
Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis (1999) 3.04
Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene (1999) 3.01
Partitioning of C-photosynthate, and long distance translocation of amino acids in preflowering and flowering, nodulated and nonnodulated soybeans. Plant Physiol (1979) 2.99
HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA (2001) 2.95
Postaxial acrofacial dysostosis syndrome. J Pediatr (1979) 2.93
Phase I cancer trials. A collusion of misunderstanding. Hastings Cent Rep (2000) 2.90
Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults. Antimicrob Agents Chemother (2001) 2.84
Nonequivalent nuclear location of immunoglobulin alleles in B lymphocytes. Nat Immunol (2001) 2.83
Self-rated health among Hispanic vs non-Hispanic white adults: the San Luis Valley Health and Aging Study. Am J Public Health (1996) 2.76
Late presentation of HIV infection: a consensus definition. HIV Med (2011) 2.67
Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder. Arch Gen Psychiatry (2000) 2.57
Migration and geographic variations in blood pressure in Britain. BMJ (1990) 2.55
Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression. J Am Acad Child Adolesc Psychiatry (1998) 2.54
Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology (1999) 2.52
Aggregative adherence fimbria II, a second fimbrial antigen mediating aggregative adherence in enteroaggregative Escherichia coli. Infect Immun (1997) 2.50
Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals. Nat Biotechnol (2001) 2.46
High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients. J Clin Microbiol (2001) 2.45
High-resolution mapping of crossovers in human sperm defines a minisatellite-associated recombination hotspot. Mol Cell (1998) 2.41
Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood (2001) 2.37
Human Gene Mutation Database: towards a comprehensive central mutation database. J Med Genet (2008) 2.37
Distribution of brain HIV load in AIDS. Brain Pathol (1998) 2.36
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial. JAMA (1999) 2.36
HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed. Ann Intern Med (1999) 2.36
EUROCARE: a cross-national study of co-resident spouse carers for people with Alzheimer's disease: I--Factors associated with carer burden. Int J Geriatr Psychiatry (1999) 2.36
Minor psychiatric morbidity and the threat of redundancy in a professional group. Psychol Med (1982) 2.36
Treatment of obesity by total fasting for up to 249 days. Lancet (1966) 2.31
Detection of inflammatory bowel disease in adults and children: evaluation of a new isotopic technique. Br Med J (Clin Res Ed) (1985) 2.30
Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study. HIV Med (2003) 2.30
Tuberculosis control and molecular epidemiology in a South African gold-mining community. Lancet (2000) 2.26
Cows' milk-sensitive enteropathy. Arch Dis Child (1978) 2.22
Association between mortality among women and socioeconomic factors in general practices in Edinburgh: an application of small area statistics. Br Med J (Clin Res Ed) (1987) 2.22
Outbreak of Pontiac fever due to Legionella anisa. Lancet (1990) 2.20
Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction (2001) 2.17
Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16
Alternative or additional medicine? A new dilemma for the doctor. J R Coll Gen Pract (1988) 2.16
Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples. AIDS (2000) 2.15
Hydroxyproline heterooligosaccharides in Chlamydomonas. Science (1972) 2.12
Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet (1993) 2.12
Arteriohepatic dysplasia: familial pulmonary arterial stenosis with neonatal liver disease. Arch Dis Child (1973) 2.11
Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study. Arch Intern Med (2000) 2.11
Diuretic action of three sulfonylurea drugs. Ann Intern Med (1973) 2.10
Mice conditionally lacking the Wolfram gene in pancreatic islet beta cells exhibit diabetes as a result of enhanced endoplasmic reticulum stress and apoptosis. Diabetologia (2005) 2.08
A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance. Antimicrob Agents Chemother (1999) 2.08
Executive cognitive abilities and functional status among community-dwelling older persons in the San Luis Valley Health and Aging Study. J Am Geriatr Soc (1998) 2.08
Cocaine/polydrug use in pregnancy: two-year follow-up. Pediatrics (1992) 2.04
CD4+ T cells: specificity and function. Immunol Rev (1988) 2.04
Factors associated with an increased case-fatality rate in HIV-infected and non-infected South African gold miners with pulmonary tuberculosis. Int J Tuberc Lung Dis (2000) 2.02
Recognition of partial defects in antidiuretic hormone secretion. Ann Intern Med (1970) 2.02
Tuberculosis in the autopsy material: analysis of 1500 autopsies performed between 1972 and 1991 in the Institute of Tuberculosis and Chest Diseases, Warsaw, Poland. Tuber Lung Dis (1995) 2.00
Human immunodeficiency virus type 1 populations in blood and semen. J Virol (1998) 1.99
Can ultrasound probes and coupling gel be a source of nosocomial infection in patients undergoing sonography? An in vivo and in vitro study. AJR Am J Roentgenol (1995) 1.97
Errors and violations on the roads: a real distinction? Ergonomics (2010) 1.96
Epidemiologic studies of diabetes in the Pima Indians. Recent Prog Horm Res (1976) 1.95
Actinobacillus actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending toxins capable of causing a G2 arrest in human T cells. J Immunol (1999) 1.95
The chemical composition of the cell wall of Chlamydomonas gymnogama and the concept of a plant cell wall protein. J Cell Biol (1974) 1.95
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med (2003) 1.94
THE RELATION OF SPECIFIC GRAVITY TO COMPOSITION AND TOTAL SOLIDS IN NORMAL HUMAN URINE. J Clin Invest (1940) 1.92
Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy. AIDS (2001) 1.92
Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues. Int J Tuberc Lung Dis (2009) 1.92
Are household firearms stored safely? It depends on whom you ask. Pediatrics (2000) 1.91